Momenta Pharmaceuticals Stock Predictions

Buy MNTA

*Your capital is at risk

$52.48

+0 (+0%)

At Close: May 27, 2022

Currently predicting for Mon, 8 Jun 2026

MNTA Prediction Chart

MNTA Predictions History

Latest community submissions for MNTA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Oct 22, 2019	$14.28 -2.06%	$14.58	X	97.94%	0
2poJeff Pro	Oct 22, 2019	$14.11 -3.22%	$14.58	X	96.78%	0
Omar.Zaied.111919	Oct 22, 2019	$14.40 -1.23%	$14.58	X	98.77%	1
GoldenNugget Pro	May 7, 2019	$14.51 +5.85%	$13.71	X	94.15%	0
NameNotImportant Pro	Apr 24, 2019	$14.32 -0.49%	$14.39	X	99.51%	4
NameNotImportant Pro	Apr 23, 2019	$13.95 -5.10%	$14.70	X	94.90%	0
JS Pro	Aug 26, 2016	$12.42 +1.80%	$12.20	X	98.20%	0
PumpTheseNumbers Pro	May 24, 2016	$10.17 -7.29%	$10.97	X	92.70%	0
PumpTheseNumbers Pro	May 20, 2016	$10.24 -1.63%	$10.41	X	98.40%	0
JS Pro	May 19, 2016	$10.24 +1.69%	$10.07	X	98.30%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MNTA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT MOMENTA PHARMACEUTICALS

Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. The companys complex generics programs include Enoxaparin sodium injection, a generic version of Lovenox that is used to prevent and treat deep vein thrombosis, and to support the treatment of acute coronary syndromes; GLATOPA, a generic version of once-daily C...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by